跳至主要内容
临床试验/NL-OMON50765
NL-OMON50765已完成2 期

Early-life stress, the endocannabinoid system, and fear memory extinction - Early-life stress, the endocannabinoid system, and fear memory extinction

Radboud Universitair Medisch Centrum0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In each substudy, in order to be eligible to participate in this study, a
  • participant must meet all of the following criteria:
  • For both groups:
  • * Healthy volunteers between 18 and 45 years of age.
  • * Predominant right-handedness.
  • * For substudy 2 only: History of taking cannabis.
  • For ELS group:
  • * Meet the criteria for ELS as measured using the self-report questionnaire
  • *Maltreatment and Abuse Chronology of Exposure Scale (MACE-X)*. There are 10
  • subscales in MACE-X, the criterion for each subscale is listed below.
  • * In the emotional neglect subscale, the cut-off is 2 items out of 5.
  • * In the parental non-verbal abuse subscale, the cut-off is 4 out of 6.
  • * In the parental physical maltreatment subscale, the cut-off is 4 items.
  • * In the parental verbal abuse subscale, the cut-off is 3 items out of 4.
  • * In the sexual abuse subscale, the cut-off is 2 items out of 7.
  • * In the witnessing interparental violence subscale, the cut-off is 2 items out
  • * In the peer verbal abuse subscale, the cut-off is 4 items out of 5.
  • * In the peer physical bullying subscale, the cut-off is 2 items out of 5.
  • * In the physical neglect, the cut-off is 2 items out of 5.
  • * In the witnessing violence to siblings subscale, the cut-off is 1 items out
  • We will include people a) who meet the criterion on any single subscale, while
  • only counting items under age of ten, or b) who meet the criteria on multiple
  • subscales regardless of age, when the sum of percentages of the cut-offs
  • reached below the age of ten for each of these subscales equals or exceeds 100.
  • For instance, if a potential participant scores 2 item on the sexual abuse
  • subscale, of which 1 is below the age of 10, and scores 5 on the verbal abuse
  • subscale, of which 3 are below the age of ten, then this participant would be
  • included because (1/2) *100 + (3/4) *100 <= 125.
  • * For Non-ELS group: We aim to recruit participants in the control group with
  • no experiences of ELS. The MACE-X has six subscales which are indicate severe
  • childhood maltreatment: Emotional Neglect, Parental Nonverbal Emotional Abuse,
  • Parental Physical Maltreatment, Parental Verbal Abuse, Sexual Abuse, or
  • Witnessing Interparental Violence. The criterion for each of these subscales is
  • listed below.
  • * In the emotional neglect subscale, the cut-off is 2 items out of 5.
  • * In the parental non-verbal abuse subscale, the cut-off is 4 out of 6.
  • * In the parental physical maltreatment subscale, the cut-off is 4 items.
  • * In the parental verbal abuse subscale, the cut-off is 3 items out of 4.
  • * In the sexual abuse subscale, the cut-off is 2 items out of 7.
  • * In the witnessing interparental violence subscale, the cut-off is 2 items out
  • And four subscales which are less relevant to severe childhood maltreatment.
  • The criterion for each of these subscales is listed below.
  • * In the peer verbal abuse subscale, the cut-off is 4 items out of 5.
  • * In the peer physical bullying subscale, the cut-off is 2 items out of 5.
  • * In the physical neglect, the cut-off is 2 items out of 5.
  • * In the witnessing violence to siblings subscale, the cut-off is 1 items out
  • We will include people into the control group who a) score 0 on the six
  • subscales most relevant to severe childhood maltreatment (SCM) listed above,
  • and b) score below the cut-off o

排除标准

  • In each study, a potential subject who meets any of the following criteria will
  • be excluded from participation in this study:
  • For both groups:
  • * Body mass index lower than 18.5 or higher than 30.
  • * Abnormal hearing or (uncorrected) vision.
  • * Average use of psychotropic medication or recreational drugs weekly or more.
  • * Habitual smoking, i.e. more than a package of cigarettes per week and a
  • self-reported
  • inability or unease to cease smoking for 24 hours prior to testing.
  • * Use of psychotropic medication, or of recreational drugs over a period of one
  • week prior to each test session, and use of alcohol within the last 24 hours
  • before each measurement.
  • * Regular use of corticosteroids.
  • * Current psychiatric treatment. (e.g., severe depression, anorexia nervosa,
  • severe mood disorders, mania, schizophrenia or borderline personality disorder)
  • * Current neurological treatment.
  • * Current endocrine treatment. (e.g., phechromocytoma, hyperthyroidism,
  • Cushing*s syndrome)
  • * Contraindication for systemic hydrocortisone (e.g., ulcus ventriculi, ulcus
  • duodeni, certain infections, and eye problems that point toward a risk
  • (closed-angle) glaucoma).
  • * History of repeated (more than once) of autonomic failure (e.g., vasovagal
  • reflex syncope).
  • * Contraindications for MRI scanning (e.g., pacemaker, implanted metal parts,
  • deep brain stimulation, claustrophobia)
  • * Metal objects in or around the body (braces, pacemaker, metal fragments,
  • hearing devices).
  • * Use of medication that may interact with hydrocortisone (study 1) or THC
  • (study 2). E.g., for Hydrocortisone, e.g., taking taking mifepristone within
  • one week before and during the study period is reason for exclusion. For THC,
  • taking rifampicin, ketoconazole, and omeprazole will not be allowed within one
  • week before and during the study period.
  • * Cognitive impairment (MMSE < 26)
  • * Pregnancy
  • * Night shift work
  • * Known enhanced risk of using THC or hydrocortisone

研究者

相似试验